29 years of historical data (1997–2025) · Consumer Defensive · Packaged Foods
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
LifeVantage Corporation trades at 8.0x earnings, 57% below its 5-year average of 18.6x, sitting at the 7th percentile of its historical range. Compared to the Consumer Defensive sector median P/E of 18.7x, the stock trades at a discount of 57%. On a free-cash-flow basis, the stock trades at 7.3x P/FCF, 43% below the 5-year average of 12.8x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $77M | $170M | $83M | $55M | $57M | $105M | $197M | $194M | $90M | $61M | $198M |
| Enterprise Value | $68M | $161M | $80M | $46M | $52M | $100M | $176M | $177M | $79M | $57M | $199M |
| P/E Ratio → | 8.00 | 17.21 | 27.91 | 21.75 | 18.13 | 8.17 | 17.11 | 25.96 | 15.54 | 39.36 | 33.17 |
| P/S Ratio | 0.34 | 0.74 | 0.42 | 0.26 | 0.28 | 0.48 | 0.85 | 0.86 | 0.44 | 0.31 | 0.96 |
| P/B Ratio | 2.28 | 4.90 | 3.21 | 1.58 | 1.80 | 2.85 | 5.94 | 7.15 | 4.10 | 4.21 | 16.29 |
| P/FCF | 7.30 | 16.17 | 8.38 | 14.54 | 8.84 | 16.31 | 12.62 | 12.72 | 10.46 | 11.03 | 36.10 |
| P/OCF | 6.46 | 14.30 | 6.84 | 8.01 | 7.14 | 13.18 | 10.77 | 10.93 | 6.79 | 9.27 | 32.74 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
LifeVantage Corporation's enterprise value stands at 4.4x EBITDA, 38% below its 5-year average of 7.2x. The Consumer Defensive sector median is 11.0x, placing the stock at a 60% discount on an enterprise-value basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 0.71 | 0.40 | 0.22 | 0.25 | 0.45 | 0.76 | 0.78 | 0.39 | 0.29 | 0.96 |
| EV / EBITDA | 4.44 | 10.51 | 10.12 | 5.89 | 4.84 | 4.74 | 8.58 | 15.55 | 6.77 | 9.38 | 13.01 |
| EV / EBIT | 5.59 | 13.23 | 18.49 | 10.84 | 11.15 | 5.67 | 11.94 | 18.54 | 7.88 | 16.41 | 16.59 |
| EV / FCF | — | 15.36 | 8.05 | 12.27 | 8.15 | 15.54 | 11.28 | 11.59 | 9.16 | 10.31 | 36.38 |
Margins and return-on-capital ratios measuring operating efficiency
LifeVantage Corporation earns an operating margin of 5.3%, roughly in line with the Consumer Defensive sector average. Operating margins have expanded from 2.0% to 5.3% over the past 3 years, signaling improving operational efficiency. Return on equity of 32.3% is exceptionally high — well above the sector median of 6.5%. ROIC of 37.5% represents excellent returns on invested capital versus a sector median of 5.7%.
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 80.4% | 80.4% | 79.3% | 79.7% | 81.5% | 82.7% | 83.7% | 83.2% | 82.9% | 83.2% | 83.6% |
| Operating Margin | 5.3% | 5.3% | 2.2% | 2.0% | 3.7% | 8.0% | 6.6% | 4.2% | 5.1% | 2.2% | 6.5% |
| Net Profit Margin | 4.3% | 4.3% | 1.5% | 1.2% | 1.5% | 5.9% | 5.0% | 3.3% | 2.8% | 0.8% | 2.9% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 32.3% | 32.3% | 9.7% | 7.7% | 9.1% | 36.8% | 38.2% | 30.2% | 31.6% | 12.1% | 77.9% |
| ROA | 14.8% | 14.8% | 4.6% | 3.7% | 4.2% | 18.7% | 20.2% | 14.0% | 12.0% | 3.4% | 13.2% |
| ROIC | 37.5% | 37.5% | 13.3% | 12.0% | 19.3% | 59.9% | 104.8% | 69.3% | 73.0% | 27.6% | 84.4% |
| ROCE | 29.5% | 29.5% | 10.3% | 9.3% | 15.4% | 40.3% | 49.1% | 33.6% | 41.9% | 20.4% | 73.0% |
Solvency and debt-coverage ratios — lower is generally safer
LifeVantage Corporation carries a Debt/EBITDA ratio of 0.8x, which is very conservative (78% below the sector average of 3.5x). The company holds a net cash position — cash of $20M exceeds total debt of $12M, providing substantial financial flexibility for buybacks, acquisitions, or weathering downturns.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.34 | 0.34 | 0.52 | 0.38 | 0.50 | 0.49 | 0.04 | 0.05 | 0.25 | 0.51 | 0.78 |
| Debt / EBITDA | 0.76 | 0.76 | 1.72 | 1.67 | 1.45 | 0.86 | 0.06 | 0.13 | 0.46 | 1.22 | 0.61 |
| Net Debt / Equity | — | -0.25 | -0.13 | -0.25 | -0.14 | -0.14 | -0.63 | -0.64 | -0.51 | -0.28 | 0.13 |
| Net Debt / EBITDA | -0.56 | -0.56 | -0.41 | -1.09 | -0.41 | -0.24 | -1.02 | -1.53 | -0.96 | -0.66 | 0.10 |
| Debt / FCF | — | -0.81 | -0.33 | -2.26 | -0.69 | -0.78 | -1.34 | -1.14 | -1.31 | -0.73 | 0.28 |
| Interest Coverage | — | — | — | — | 470.10 | 1036.18 | 123.17 | 29.58 | 21.94 | 6.11 | 3.61 |
Net cash position: cash ($20M) exceeds total debt ($12M)
Short-term solvency ratios and asset-utilisation metrics
A current ratio of 1.87x means LifeVantage Corporation can comfortably meet its short-term obligations, though there is limited excess liquidity. The quick ratio of 1.11x is notably lower than the current ratio, indicating a significant portion of current assets is tied up in inventory. The current ratio has declined from 2.26x to 1.87x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.87 | 1.87 | 1.69 | 2.26 | 1.83 | 1.91 | 1.75 | 1.65 | 1.64 | 1.52 | 1.49 |
| Quick Ratio | 1.11 | 1.11 | 1.01 | 1.44 | 1.18 | 1.27 | 1.20 | 1.12 | 1.06 | 0.81 | 0.61 |
| Cash Ratio | 0.74 | 0.74 | 0.76 | 1.10 | 0.78 | 0.92 | 0.88 | 0.72 | 0.70 | 0.49 | 0.28 |
| Asset Turnover | — | 3.18 | 3.32 | 3.23 | 2.92 | 2.80 | 3.96 | 4.09 | 3.97 | 4.41 | 4.11 |
| Inventory Turnover | 2.17 | 2.17 | 2.75 | 2.70 | 2.31 | 2.37 | 2.73 | 2.76 | 2.56 | 2.02 | 1.35 |
| Days Sales Outstanding | — | 6.28 | 5.95 | 3.17 | 9.00 | 6.57 | 4.09 | 5.33 | 4.52 | 4.11 | 2.74 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
LifeVantage Corporation returns 10.2% to shareholders annually — split between a 2.6% dividend yield and 7.6% buyback yield. The payout ratio of 21.1% is conservative, leaving significant room for dividend growth or reinvestment. The earnings yield of 12.5% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 2.6% | 1.2% | 8.3% | 2.9% | 0.7% | 0.4% | — | — | — | — | — |
| Payout Ratio | 21.1% | 21.1% | 236.3% | 62.4% | 12.1% | 2.9% | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 12.5% | 5.8% | 3.6% | 4.6% | 5.5% | 12.2% | 5.8% | 3.9% | 6.4% | 2.5% | 3.0% |
| FCF Yield | 13.7% | 6.2% | 11.9% | 6.9% | 11.3% | 6.1% | 7.9% | 7.9% | 9.6% | 9.1% | 2.8% |
| Buyback Yield | 7.6% | 3.4% | 9.2% | 1.9% | 16.0% | 8.7% | 5.9% | 4.0% | 1.7% | 0.0% | 0.0% |
| Total Shareholder Yield | 10.2% | 4.6% | 17.5% | 4.8% | 16.6% | 9.0% | 5.9% | 4.0% | 1.7% | 0.0% | 0.0% |
| Shares Outstanding | — | $13M | $13M | $13M | $13M | $14M | $15M | $15M | $14M | $14M | $15M |
Compare LFVN with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
| $77M | 8.0 | 4.4 | 7.3 | 80.4% | 5.3% | 32.3% | 37.5% | 0.8 | |
| $359M | 19.2 | 7.4 | 12.4 | 72.4% | 5.2% | 12.1% | 21.0% | 0.5 | |
| $19M | -21.8 | — | — | 73.5% | -4.5% | -3.1% | -6.5% | — | |
| $746M | 161.0 | 21.3 | 9.0 | 10.1% | 0.6% | 2.0% | 2.8% | 0.3 | |
| $1B | 5.5 | 5.8 | 5.0 | 75.6% | 8.8% | — | 24.3% | 4.2 | |
| $349M | 32.6 | 2.3 | 40.9 | 78.3% | 5.5% | 1.8% | 8.6% | 0.2 | |
| $243M | 1.6 | 2.6 | 5.3 | 69.4% | 6.1% | 22.0% | 7.3% | 2.5 | |
| $138M | -11.4 | 123.1 | — | 71.0% | -4.9% | -247.8% | -2.6% | 81.5 | |
| $853M | 23.2 | 10.1 | 11.6 | 28.4% | 11.1% | 12.5% | 16.2% | 1.0 | |
| $7B | 65.8 | 52.5 | 99.6 | 73.8% | 4.5% | 25.2% | 8.6% | 7.9 | |
| $2.5T | 32.5 | 17.6 | 325.3 | 50.3% | 11.2% | 22.3% | 14.7% | 1.0 | |
| Consumer Defensive Median | — | 18.7 | 11.0 | 15.6 | 40.7% | 3.4% | 6.5% | 5.7% | 3.5 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Includes 30+ ratios · 29 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying LFVN stock.
LifeVantage Corporation's current P/E ratio is 8.0x. The historical average is 22.2x. This places it at the 7th percentile of its historical range.
LifeVantage Corporation's current EV/EBITDA is 4.4x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 16.3x.
LifeVantage Corporation's return on equity (ROE) is 32.3%. This is above the typical threshold of 15-20% considered good for most companies. The historical average is 7.2%.
Based on historical data, LifeVantage Corporation is trading at a P/E of 8.0x. This is at the 7th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
LifeVantage Corporation's current dividend yield is 2.62% with a payout ratio of 21.1%.
LifeVantage Corporation has 80.4% gross margin and 5.3% operating margin.
LifeVantage Corporation's Debt/EBITDA ratio is 0.8x, indicating low leverage. A ratio below 2x is generally considered financially healthy.